Author

A.J. Joshi

Observed name: Abhishek Joshi

Institutions: Townsville Hospital, James Cook University

Observed institutions: Townsville Hospital, James Cook University

ORCID: 0000-0002-7786-0039

Observed ORCIDs: 0000-0002-7786-0039, 0000-0003-2632-0646

OpenAlex ID: A5018742389

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial

2024 · Marcin Dzienis, Juan Cundom, et al. · Journal of Clinical Oncology · 67

651O Pembrolizumab (pembro) + carboplatin (carbo) + paclitaxel (pacli) as first-line (1L) therapy in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Phase VI KEYNOTE-B10 study

2022 · M.R. Dzienis, J.E. Cundom, et al. · Annals of Oncology · 22

Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line (1L) Pembrolizumab (pembro) + Carboplatin (carbo) + Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

2024 · M. Dzienis, J. Cundom, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

Cost-Effectiveness Analysis of an Intracranial Stereotactic Radiotherapy Service for Brain Metastasis in a North Queensland Regional Cancer Centre

2026 · Qichen Zhang, Lan Gao, et al. · Cancers

Works count: 4

Citation count: 92

H-index: 3

I10-index: 2